Skip To Main Content
Mengying Hu on Muck Rack

Mengying Hu

As seen in: Color Research & Application, Nature, Wiley Online Library, Frontiers, MDPI, Science Magazine, BioRxiv, Cell Press, Physical Review B, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mengying

Contact Mengying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Beyond Muscle Mass: Interpreting TBMM as a Marker of Geriatric Vulnerability in Acute Heart Failure

|
By Mengying Hu, Y. Ikeda, Yaqun Tang
| Wiley Online Library Verified
No abstract is available for this article. Data Availability Statement Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. References 1, , , et al., “Prognostic Utility of the Total Body Muscle Mass in Heart Failure: Insights From the JEDI-AHF Registry,” Geriatrics & Gerontology International 26, no. 7 (2026): e70680, https://doi.org/10.1111/ggi.70680.
Open in Who Shared Issue with article?

Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity

|
By Mengying Hu, Di-Ao Liu, Inbal Wortzel, Paul Collier, Theodore Nelson, Jonathan Foox, Guojie Zhong, Gabriel Tobias, Tetsuhiko Asao, Linda Bojmar, Candia M. Kenific, Gang Wang, Simone Caielli, Zurong Wan, Sarah A. Qureshy, Max Reed, Richard Piszczatowski, Purnima Ravisankar, Julia Brown, Sihan Xiong, Huajuan Wang, Pernille Lauritzen, Yael Aylon, Henrik Molina, William R. Jarnagin, Moshe Oren, Ben Z. Stanger, Jack D Bui, Gabriele Bergers, Agnès Noël Verified, Paul M. Grandgenett, Michael A Hollingsworth, David A. Tuveson, Nancy Boudreau, Jacqueline F. Bromberg, David P. Kelsen, Laura Santambrogio, Melody Y. Zeng, Virginia Pascual, Christopher E. Mason, Haiying Zhang, Irina Matei, David Lyden Verified
| Cell Press Verified
STAR★Methods REAGENT or RESOURCESOURCEIDENTIFIER Antibodies TruStain FcX™ PLUS (anti-mouse CD16/32) Antibody (clone S17011E) Biolegend Cat#156603; RRID: AB_2783137 Brilliant Violet 510™ anti-mouse CD45 Antibody (clone 30-F11) Biolegend Cat#103138; RRID: AB_2563061 Alexa Fluor® 647 anti-mouse CD3 Antibody (clone 17A2) Biolegend Cat#100209; RRID: AB_389323 Brilliant Violet 650™ anti-mouse/human CD45R/B220 Antibody (clone RA3-6B2) Biolegend Cat#103241; RRID: AB_11204069 PerCP/Cyanine5.5...
Open in Who Shared Issue with article?

Psychosocial barriers and cultural contexts in chemotherapy decision-making: a qualitative study of advanced lung cancer patients in China

|
By Qing Wang, Jun Zhang, Mengying Hu, Jiaojiao Xu, Jiao Yu, Haiping Ma, Qiongqiong Ai, Hequn Wei
| Frontiers
1 Introduction Lung cancer, a heterogeneous malignancy originating from bronchial mucosal epithelium or glandular tissues, constitutes a major global public health challenge, with persistently elevated incidence and mortality rates (1). Current epidemiological evidence demonstrates that over 60% of cases are diagnosed at advanced stages (III/IV), and lung cancer is often diagnosed at advanced stages when treatment options are limited (2, 3).
Open in Who Shared Issue with article?
See all 16 articles